ClinicalTrialsFinder
RecruitingNot ApplicableNCT04226313

Self-sampling for Non-attenders to Cervical Cancer Screening

Cervical Cancer Prevention Using Self-sampling and Human Papillomavirus Detection

Sponsor

The Institute of Molecular and Translational Medicine, Czech Republic

Enrollment

15,000 participants

Start Date

Sep 23, 2019

Study Type

INTERVENTIONAL

Conditions

Cervical CancerCervical DysplasiaHuman Papillomavirus Infection

Summary

The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.

Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether mailing self-sampling kits for cervical cancer screening to women who have not had a smear test in at least 3 years encourages them to participate. You may be eligible if: you are a woman between 30 and 65 years old (or over 65 for one specific arm); you live in the Czech Republic; you have not participated in cervical cancer screening in at least 3 years; you can self-collect a vaginal swab; and you have given your informed consent. You may NOT be eligible if: you are pregnant; you have never had sexual intercourse; or you have had a hysterectomy that included removal of the cervix. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSelf-sampling by Evalyn Brush

Women will perform a cervicovaginal self-sampling at their home using Evalyn Brush.

DIAGNOSTIC_TESTSelf sampling by Evalyn Brush home or in GP´s clinic

Women will perform a cervicovaginal self-sampling at their home or the GP´s clinic using Evalyn Brush

Locations(1)

University Hospital Olomouc

Olomouc, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04226313

Related Trials

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

NCT0721670387 locations

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

NCT06459180240 locations

DESTINY-PANTUMOUR04

NCT0712400017 locations

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

NCT052833304 locations

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT068144962 locations